•
Dec 31, 2022
AbCellera Q4 2022 Earnings Report
AbCellera reported its Q4 2022 earnings, highlighting a net loss and revenue contribution from royalties and research fees.
Key Takeaways
AbCellera's Q4 2022 saw revenue of $21.5 million, with $9.5 million from royalties and $11.4 million from research fees. The company experienced a net loss of $29.9 million, or ($0.10) per share.
Total revenue for Q4 2022 was $21.5 million.
Royalties from bebtelovimab contributed $9.5 million to Q4 revenue.
Research fees generated $11.4 million in Q4.
Net loss for Q4 was $29.9 million, or ($0.10) per share.
AbCellera
AbCellera
AbCellera Revenue by Segment
Forward Guidance
No specific forward guidance was provided in the press release.